Elmind Capital, LP
CIK: 0002052213SEC EDGAR →
Portfolio Value
$338.9M
Holdings
34
As of
Q4 2025
New Positions
34
Closed Positions
0
Portfolio Value History
No historical data available yet. Chart will appear after multiple quarterly filings.
Top 10 Holdings
| Rank | Stock | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | COGENT BIOSCIENCES INC | 1,170,740 | $41.6M | 12.27% |
| 2 | SYNDAX PHARMACEUTICALS INC | 1,855,000 | $39.0M | 11.50% |
| 3 | VIRIDIAN THERAPEUTICS INC | 858,631 | $26.7M | 7.89% |
| 4 | VERA THERAPEUTICS INC | 482,500 | $24.4M | 7.21% |
| 5 | CELLDEX THERAPEUTICS INC NEW | 865,000 | $23.5M | 6.93% |
| 6 | CG ONCOLOGY INC | 492,500 | $20.4M | 6.03% |
| 7 | BIOCRYST PHARMACEUTICALS INC | 2,150,000 | $16.8M | 4.95% |
| 8 | VAXCYTE INC | 291,500 | $13.4M | 3.97% |
| 9 | BEAM THERAPEUTICS INC | 476,338 | $13.2M | 3.90% |
| 10 | PHARVARIS N V | 475,750 | $13.2M | 3.90% |
Sector Breakdown
| Sector | # Holdings | Value | % |
|---|---|---|---|
| Healthcare | 32 | $310.0M | 91.5% |
| Unknown | 2 | $28.9M | 8.5% |